Therapeutics Equities

TG Therapeutics (TGTX) Technical Analysis: A Bullish Breakout Mar 21, 2025

Q2 Earnings Forecast for TG Therapeutics Issued by B. Riley Mar 9, 2025

HC Wainwright Updates Earnings Estimate for Protagonist Therapeutics in Q1 2025 Feb 27, 2025

Checkpoint Therapeutics CEO James F. Oliviero III Sells Shares Feb 12, 2025

Atossa Therapeutics, Inc. Short Interest Declines by 6.8% in November Dec 16, 2024

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Analysts Favor a 'Buy' Recommendation Nov 3, 2024

TG Therapeutics (TGTX) Set to Report Quarterly Earnings Nov 2, 2024

Gain Therapeutics Announces Participation in Investor Conferences Oct 3, 2024

Capricor Therapeutics Scheduled to Update Investors on Duchenne Muscular Dystrophy Program Sep 23, 2024

Summit Therapeutics Stock Surges on Positive Clinical Results Sep 10, 2024

Unicycive Therapeutics Announces Successful Outcome for Oxylanthanum Carbonate (OLC) in Pivotal Trial Jun 26, 2024

The Pneumonia Therapeutics Market Set for Robust Growth, Expected to Reach USD 5.7 Billion by 2031 Feb 19, 2024

Unicycive Therapeutics Announces Upcoming Milestones in Shareholder Update Jan 23, 2024

Bionomics to Showcase BNC210 Developments at Biotech Showcase™ 2024 Jan 6, 2024

Inhibikase Therapeutics Updates Shareholders on Development Progress Dec 19, 2023

Vandria Secures $20.6M in Series A Funding to Propel CNS Clinical Program and Mitochondrial Therapeutics Development Dec 15, 2023